We are live on ! Find out more
BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of BCLI yet.

BCLI Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q4 2025, worth a combined $0 — down 100% from $1.73K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BCLI and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Osaic Holdings, exiting entirely with an estimated $1.35K sold.

  • 0 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q4 2025, down from 5 in Q3 2025.
  • Funds reported $0 of BRAINSTORM CELL THERAPUTC stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new BRAINSTORM CELL THERAPUTC positions in Q4 2025 and 5 closed out, a net change of -5 holders.
  • The largest BRAINSTORM CELL THERAPUTC seller in Q4 2025 was Osaic Holdings, an estimated $1.35K sold.

Based on aggregated 13F filings for Q4 2025.